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Limb-girdle	muscular	dystrophy	type	2A	(LGMD2A)	is	a	genetic	disease	that	is	caused	by	mutations	in	the	cal-
pain	3	gene	(CAPN3),	which	encodes	the	skeletal	muscle–specific	calpain,	calpain	3	(also	known	as	p94).	How-
ever,	the	precise	mechanism	by	which	p94	functions	in	the	pathogenesis	of	this	disease	remains	unclear.	Here,	
using	p94	knockin	mice	(termed	herein	p94KI	mice)	in	which	endogenous	p94	was	replaced	with	a	proteolyti-
cally	inactive	but	structurally	intact	p94:C129S	mutant	protein,	we	have	demonstrated	that	stretch-dependent	
p94	distribution	in	sarcomeres	plays	a	crucial	role	in	the	pathogenesis	of	LGMD2A.	The	p94KI	mice	developed	a	
progressive	muscular	dystrophy,	which	was	exacerbated	by	exercise.	The	exercise-induced	muscle	degeneration	
in	p94KI	mice	was	associated	with	an	inefficient	redistribution	of	p94:C129S	in	stretched	sarcomeres.	Further-
more,	the	p94KI	mice	showed	impaired	adaptation	to	physical	stress,	which	was	accompanied	by	compromised	
upregulation	of	muscle	ankyrin-repeat	protein-2	and	hsp	upon	exercise.	These	findings	indicate	that	the	stretch-
induced	dynamic	redistribution	of	p94	is	dependent	on	its	protease	activity	and	essential	to	protect	muscle	from	
degeneration,	particularly	under	conditions	of	physical	stress.	Furthermore,	our	data	provide	direct	evidence	
that	loss	of	p94	protease	activity	can	result	in	LGMD2A	and	molecular	insight	into	how	this	could	occur.
Introduction
Limb-girdle muscular dystrophy (LGMD) is a genetically hetero-
geneous group of disorders involving progressive muscle weakness 
and atrophy of the truncal and proximal limb muscles, elevated 
serum creatine kinase (CK) levels, and dystrophic changes visible 
in muscle biopsy sections (1–4). To date, 452 distinct pathogen-
ic mutations of the CAPN3 gene, which encodes p94/calpain 3, 
have been found in LGMD2A patients (5, 6). p94 is a member of 
the calpain family, which consists of Ca2+-requiring intracellular 
cysteine proteases that cleave their substrates at a few specific 
sites to modulate the substrate’s function (7, 8). The mutations 
of the p94-encoding CAPN3 gene are distributed along the entire 
length of the gene product and include missense, nonsense, frame-
shift, and deletion mutations (3, 6, 9–11). These findings, as well 
as p94 Tg (12) and KO mouse studies (13, 14), indicate that p94 
plays an essential role(s) in skeletal muscle. However, the precise 
mechanism by which the diverse p94 mutations contribute to the 
LGMD2A pathology is still largely unknown.
In myofibrils, p94 directly interacts with connectin/titin at the 
M-line and N2A regions (15), where multiple protein complexes 
that use connectin/titin as a scaffold form. These complexes are 
thought to associate with myofibrillar signal–transduction sys-
tems (16). In the N2A region of connectin/titin, a binding site 
for muscle ankyrin repeat proteins (MARPs), which are stress-
response transcriptional regulator proteins, overlaps with that 
for p94, and MARP2/Ankrd2 is proteolyzed by p94 with the 
structural aid of connectin/titin, which may modulate stress-
dependent signal transduction (17, 18). Our previous in vitro 
study demonstrated that p94 shifts its location from the M-line 
to the N2A region when the sarcomere is extended, suggesting 
that p94 functions as a sarcomere-length sensor in coopera-
tion with connectin/titin (19) to mediate signal transduction in 
response to external stress.
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Figure 1
MD phenotypes in p94KI mice. (A–J) H&E-stained TA muscle sections from WT (A, C, E, G, and I) and p94KI (B, D, F, H, and J) mice of the 
ages indicated. p94KI showed typical dystrophic phenotypes, such as cell invasion (dotted circles), central nuclei (black arrowheads), and the 
splitting of myofibers (white arrowheads). Scale bars: 100 μm. (K and L) Increased CNM during aging in p94KI mice. The number of CNM in the 
TA (K) and soleus (L) was compared with the number of total myofibers. (M) Frequency distribution of myofiber CSArs in the soleus of mice over 
90 weeks old. A total of 302 fiber profiles was traced in each section from 3 mice of each type. The average myofiber CSAr was 1,542 μm2 in 
WT mice and 1,342 μm2 in p94KI mice. The fiber size in p94KI mice was significantly smaller than in WT mice (P < 0.01). White bars, WT; black 
bars, p94KI. (N) The mean serum CK level (IU/l) in p94KI mice appeared higher than in WT, but this difference was not statistically significant. 
*P < 0.05 versus WT. (O and P) Ultrastructural analysis showed a typical striated pattern with properly assembled sarcomeres in a 91-week-old 
p94KI mouse (P) with no apparent difference from the pattern of a 26-week-old WT mouse (O). Scale bars: 1 μm.
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Here, we hypothesized that the p94 protease activity is essential 
for the signal-transduction pathway by which muscles adapt to 
physical stress, the perturbation of which leads to LGMD2A. To 
test this hypothesis, we generated p94:C129S knockin (p94KI) 
mice that express a protease-inactive p94 mutant in place of WT 
p94. The p94KI mice, in contrast to conventional KO (p94KO) 
mice, express a p94:C129S protein with an intact structure under 
the control of the endogenous p94 promoter. The p94KI mice 
showed MD phenotypes, which were exacerbated by exercise. 
Importantly, our results showed that the p94 protease activity con-
tributed to the dynamic change in the distribution of p94 in myo-
cytes in response to sarcomere conditions and its loss impaired 
a stress-response pathway involving MARPs and hsp. Thus, our 
p94KI mouse enabled us to assess the loss of p94 protease func-
tion in skeletal muscle without superimposing potential structural 
defects and provided evidence linking the dysfunction of p94 with 
the LGMD2A pathological mechanism.
Results
p94KI mice showed progressive muscle degeneration/regeneration dur-
ing aging. To address the role of p94 in LGMD2A pathogenesis, 
we created mice that expressed p94:C129S in place of WT p94 
(Supplemental Figure 1; supplemental material available online 
with this article; doi:10.1172/JCI40658DS1). The resultant 
p94KI mice were fertile, with a normal lifespan. However, the 
skeletal muscles (tibialis anterior [TA] and soleus) of the p94KI 
mice showed typical MD symptoms, such as split myofibers and 
centrally located nuclei, and this pathology was exacerbated with 
age (Figure 1, A–J). The proportion of centrally nucleated myofi-
bers (CNM) in both the TA and soleus of p94KI mice was signifi-
cantly higher than in WT mice (Figure 1, K and L). The average 
myofiber cross-sectional areas (CSArs) in the soleus muscles of 
WT and p94KI mice at more than 90 weeks of age were 1,542 μm2 
and 1,342 μm2, respectively, which were significantly differ-
ent (P < 0.01) (Figure 1M). The serum CK level, another typical 
marker for MD indicative of muscle membrane damage, was not 
significantly different between the p94KI and WT mice, demon-
strating that no significant membrane damage occurred in the 
p94KI mice (Figure 1N). The ultrastructure of the p94KI mouse 
muscle was also normal and not markedly different from that of 
WT mice (Figure 1, O and P). Thus, the p94KI mice had a gradu-
ally progressive MD phenotype that worsened with age without 
severe sarcolemmal disruption. In contrast, both human patients 
with CAPN3-null mutations and p94KO mice show a more severe 
MD phenotype (9, 10, 13, 14). This difference in disease severity 
between these cases of MD and that seen in the p94KI mice sug-
gests that p94 has functions other than its role in proteolysis 
that are involved in MD pathology.
Exercise-provoked muscle degeneration in p94KI mice. In humans, 
eccentric exercise has been shown to cause p94 autolysis (20). This 
observation suggests that the p94 protease activity plays a role in 
the adaptive response of muscles to exercise. Therefore, we next 
investigated whether exercise affects MD pathogenesis in p94KI 
mice. We subjected p94KI and WT mice to downhill treadmill 
running and assessed the biochemical and pathological changes 
in their skeletal muscles. Immunoblot analysis revealed that p94 
underwent proteolysis during exercise (Figure 2, A and B) and that 
its distribution shifted from the precipitate (Ppt; myofibril) to the 
supernatant (Sup; cytosol) fraction in WT but not in p94KI mice 
during exercise (Supplemental Figure 2). The degeneration of myo-
fibers due to membrane disruption, as revealed by the incorpora-
tion of Evans blue dye (EBD), was clearly observed in the exercised 
p94KI (p94KI-ex) mice but was barely detectable in the exercised 
WT (WT-ex) mice (Figure 2, C–N). EBD-containing myofibers 
were observed among all the CSAr classes in the p94KI-ex muscle, 
indicating that membrane disruption was not exacerbated in par-
ticular classes of muscle fibers (Supplemental Figure 3). Consis-
tent with these findings, the serum CK level in the p94KI-ex mice 
was significantly higher than in the WT-ex or unexercised p94KI 
mice (Figure 2O). The proportion of CNMs was also significantly 
increased in the p94KI but not WT mice 10 days after exercise (Fig-
ure 2, P and Q). These results clearly indicate that the p94 protease 
activity is required to protect myofibers from undergoing degen-
eration under exercise-induced stress.
Skeletal muscles have the ability to self repair rapidly in response 
to injury or disease (21). After exercise, the damaged muscles in the 
p94KI mice began to regenerate (Supplemental Figure 4). The infil-
tration of mononuclear cells into the injured muscle was observed 
on postexercise days 1–3, and regenerating thin myofibers were 
observed on postexercise day 10, although these myofibers were 
heterogeneous, with the appearance of dystrophic degeneration. 
These results suggested that a lack of p94 proteolytic activity does 
not affect the regenerative potential of satellite cells.
The p94 exchange rate in myofibrils is fine tuned by its protease activity. 
To understand the molecular mechanisms by which p94 pro-
tects muscles, we analyzed the intracellular behavior of p94. 
We previously demonstrated that p94 has a stretch-dependent 
distribution (19) and that it associates physically and function-
ally with sarcomeric proteins, including connectin/titin and 
MARP2 (17). We therefore compared the dynamic behavior 
of p94 in WT and p94KI mouse myocytes using fluorescence 
recovery after photobleaching (FRAP) with GFP-tagged WT 
p94 and p94:C129S (GFP-p94WT and GFP-p94CS) expressed 
in primary cultured myotubes from WT and p94KI mice. The 
GFP signals for both GFP-p94WT and GFP-p94CS were pre-
dominantly detected at the M-line of connectin/titin (ref. 19 
and Figure 3, A and B). The FRAP experiments revealed that the 
GFP-p94WT proteins at the M-line were dynamically mobile, 
with a recovery t1/2 of 66.5 s (Figure 3C). This turnover rate was 
nearly as rapid as that of the α-actinin fast mobile fraction 
(t1/2 = 61 ± 11 s) (22). Notably, GFP-p94CS showed a signifi-
cantly longer recovery t1/2 (129 s) than GFP-p94WT (Figure 3C; 
Supplemental Figures 5 and 6). These results indicated that p94 
is dynamically located in the strictly organized sarcomere and 
that its mobility rate is fine tuned by its protease activity.
p94’s protease activity is required for its dynamic redistribution in 
response to mechanical loading. Many myofibril-associated proteins 
that display a dynamic distribution within myofibers are mechan-
ically sensitive and are thought to play an important role in the 
adaptive response to mechanical perturbation (23). Therefore, we 
further investigated the dynamic behavior of p94 in response to 
mechanical loading. We previously reported that the myofibrillar 
localization of exogenously expressed p94 shifts from the M-line 
to the N2A region of connectin/titin during sarcomeric stretch, 
using cultured myocytes (19). Consistent with this result, we 
found that p94 was predominantly located at the N2A region of 
stretched sarcomeres in both WT and p94KI mice (Figure 3, D–O). 
Importantly, the M/N2A ratio of p94 became smaller as the sar-
comeres stretched (Figure 3P). This means that as the sarcomeres 
extend, p94 tends to accumulate in the N2A region. These results 
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Figure 2
Exercise-induced myofiber degeneration in p94KI. (A and B) Immunodetection of p94 and its fragments (black and white arrowheads, respec-
tively) in WT, WT-ex, p94KI, and p94KI-ex mice. The Sup fraction from TA was subjected to Western blot analysis using an anti-pIS2C Ab (A). 
Hairlines indicate lanes that were run on the same gel but were noncontiguous. The p94 bands were quantified by normalizing to the CBB-stained 
actin (CBB in A) (B). cont, COS-expressed p94:C129S. *P < 0.01. (C–N) Damaged myofibers in the gastrocnemius muscles from WT, WT-ex, 
p94KI, and p94KI-ex mice were detected by an anti-laminin α2 Ab (C–F) and EBD autofluorescence (G–J). Merged images plus nuclei (K–N). 
Scale bars: 100 μm. (O) Drastic increase in the serum CK level in p94KI-ex. Blood samples of WT-ex and p94KI-ex were taken immediately after 
excise. (P and Q) The proportion of CNM in p94KI was significantly increased after exercise. The TA (P) and soleus (Q) from WT, p94KI, WT-ex, 
and p94KI-ex sacrificed 10 days after exercise were analyzed. The proportion of CNMs was calculated as in Figure 1. *P < 0.05 versus WT; 
**P < 0.05 versus p94KI; ***P < 0.05 versus WT-ex.
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indicate that the amount of p94 that dynamically redistributes 
from the M-line to the N2A region can quantitatively reflect the 
exercise load of myofibers. Importantly, in p94KI mice, the accu-
mulation of p94 in the N2A region during sarcomeric extension 
took significantly longer than in WT, indicating that the p94 
protease activity is required for p94’s rapid dynamic redistribu-
tion in response to mechanical loading.
Loss of p94 protease activity impairs the MARP2 response to physical 
stress. What is the significance of the p94 redistribution from the 
M-line to the N2A region in LGMD2A pathogenesis? Given the 
importance of the connectin/titin N2A region as a scaffold for vari-
ous signaling molecules (18, 24), we hypothesized that the exercise-
dependent redistribution of p94 regulates signaling molecules at 
the N2A region, inducing an adaptive response to protect muscles 
from exercise-induced degeneration. To test this hypothesis, we 
focused on MARP2/ANKRD2, since MARP2 interacts directly with 
connectin/titin at the N2A region (15, 25), where it competes with 
p94 (17). In addition, MARP2’s expression is sensitive to muscle 
conditions (26, 27), and it modulates transcription factors such as 
YB1, PML, and p53 by binding them (28). Consistent with these 
reports, we observed that the MARP2 protein was increased in WT-
ex mice compared with WT mice (Figure 4, A and B; Supplemen-
tal Figure 7). In contrast, the p94KI-ex mice showed a significant 
decrease in MARP2 in comparison with all the other types of mice. 
This impairment in MARP2 induction upon exercise was also con-
firmed by immunohistochemical analysis (Figure 4, C–N; Supple-
mental Figure 8). MARP2-positive nuclei were found in WT, p94KI, 
WT-ex, and p94KI-ex mice as 2.3%, 1.3%, 14%, and 4.8% of the total 
nuclei, respectively. These were confirmed to be myonuclei and did 
not originate from satellite cells (Supplemental Figure 9). These 
results suggested the important notion that the p94 protease activ-
ity is required for MARP2 induction in response to exercise.
Next, we determined whether the MARP2 induction upon exer-
cise has a role in preventing muscle degeneration. WT and p94KI 
mice, into which EBD was injected before exercise, were subjected 
to downhill running on a treadmill and sacrificed immediately after 
the exercise. In the WT-ex mice, EBD was incorporated into several 
myofibers in which MARP2 expression was induced, although not 
all the MARP2-positive myofibers were positive for EBD (Figure 5, 
A–C). Even in the EBD-positive myofibers, the localization of dys-
ferlin was normal (Figure 5, G–I), indicating that the sarcolemma 
was not markedly disrupted, as previously reported (29, 30). In con-
trast to the WT-ex mice, in the p94KI-ex mice, the myofibers that 
were positive for EBD showed weaker MARP2 signals and abnor-
mal dysferlin localization (Figure 5, D–F and J–L). These results 
indicated that the exercise provoked plasma membrane disruption 
and myofiber degeneration in the p94KI mice.
Molecular states of p94KI mice mimic those of WT-ex mice. To further exam-
ine pathophysiological alterations in p94KI mice, we analyzed their 
proteomes using TA muscles from WT, WT-ex, p94KI, or p94KI-ex 
mice with the iTRAQ/LC-MALDI systems. Among 660 proteins iden-
tified, 44 were upregulated (p94KI/WT > 1.2) and 18 were downregu-
lated (WT/p94KI > 1.2) in p94KI mice compared with WT (Supple-
mental Figure 10). DNA microarray analysis showed that mRNA levels 
of these proteins were unchanged with a few exceptions (Supplemental 
Figure 10 and Supplemental Table 1), indicating that these changes 
were largely at the protein level. Surprisingly, the amounts of all of 
proteins upregulated in p94KI were increased (or unchanged), and 
not decreased, in WT-ex mice compared with WT with only one excep-
tion; in contrast, proteins downregulated in p94KI were decreased (or 
unchanged) in WT-ex (compare p94KI/WT and WT-ex/WT in Supple-
mental Figure 10). This synchronicity strongly suggests that molecular 
conditions in the cytosol of cells that have been altered by p94:C129S 
mutation are nearly identical to those in the WT-ex mice. To reveal the 
underlying molecular mechanisms, we classified the expression pro-
files as indicated in Table 1 by focusing on proteins that responded to 
exercise differentially in WT and p94KI mice, i.e., categories [WT↑ and 
p94KI → or ↓] and [WT↓ and p94KI↑ or →] in Table 1.
These categories correspond to proteins that are up- or down-
regulated by exercise in WT mice but that failed to be altered in 
p94KI mice. Notably, MARP2 and –10 of the 13 identified hsp-
related molecules (including 6 small hsp [sHSP], important for 
muscle cell homeostasis; ref. 19) were included in category [WT↑ 
and p94KI → or ↓]. MARP2 data is consistent with the above West-
ern blot analysis. Other proteins in category [WT↑ and p94KI → 
or ↓] included hexokinase 2, a rate-limiting enzyme for glycolysis, 
factors involved in protein translation, and proteasome subunits, 
which may contribute to the turnover of muscle cells (see Supple-
mental Figure 10 legend). These results suggest that p94 protease 
activity regulates the levels of the proteins in categories [WT↑ and 
p94KI → or ↓] and [WT↓ and p94KI↑ or →] with exercise.
Altogether, our results support the idea that p94 plays an 
important role in MD pathogenesis, particularly in the exer-
cise-mediated exacerbation of MD, through its dynamic spatial 
configuration–dependent regulation of MARP2 expression and 
protein-level upregulation of hsp.
Discussion
Using p94KI mice, here we present the first direct and conclusive 
evidence that the loss of p94 protease activity causes LGMD2A, 
which is aggravated by age or exercise. We showed that in myo-
cytes, the loss of p94 protease activity causes (a) a slow exchange 
rate of p94 molecules at the M-line, (b) sluggish accumulation of 
p94 at the N2A region in response to sarcomeric extension, and 
(c) impaired upregulation of MARP2 and hsp levels in response 
to physical stress. Our results support the idea that p94 protease 
activity plays a key role in the pathogenesis of LGMD2A.
Figure 3
Translocation of p94 in response to sarcomeric length. (A–C) Direct 
observation of rapid GFP-p94 exchange in cultured myotubes by 
FRAP. GFP-p94WT and GFP-p94CS were exogenously expressed in 
cultured myotubes from WT (A) and p94KI (B) mice and were predom-
inantly localized to the M-lines of connectin/titin. Reference images 
were acquired before photobleaching (Pre). Rectangles indicate the 
photobleached areas. The signals in the M-line were calculated as 
the ratio of GFP intensity at the indicated time points, and exponential 
curves were fitted (C). The mobile fraction (M), rate constant (k), and 
recovery half-time (t1/2) were calculated from the FRAP curve. Note that 
a single exponential fit provided the best result, and k (i.e., t1/2) was sig-
nificantly different between WT and p94KI (see Supplemental Figures 
5 and 6). (D–P) Confocal micrographs of p94 localization in longitudi-
nal sections of EDL from WT (D–F and J–L) and p94KI (G–I and M–O) 
mice. p94, the Z-bands, and connectin/titin N2A region were detected 
with anti-pNS (E, H, K, and N), anti–s-α-actinin (D and G; arrows), 
and anti-connectin/titin-N2A (J and M; arrows) Abs, respectively. p94 
was localized to the M-lines (open arrowheads), N2A regions, and/or 
Z-bands (brackets) of both mice, but predominantly to the N2A regions 
in extended sarcomeres (K and N). Ratio of the p94 signal in the M-line 
to that in the N2A region was plotted against the sarcomeric length (P). 
The 2 estimated lines were statistically shown to be significantly differ-
ent (see Supplemental Figure 6 legend). Scale bars: 10 μm.
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Consistent with our previous in vitro observations (19), p94 
changed its in vivo location from the M-line to the N2A region 
as sarcomeres lengthened, indicating that it undergoes a sarco-
mere-length–dependent redistribution in vivo. Importantly, the 
swiftness of p94’s redistribution was dependent on its protease 
activity. Furthermore, our FRAP study showed that the M-line/
cytosol exchange rate (recovery t1/2) of the p94:C129S molecules 
was approximately twice as slow as that of WT p94. These find-
ings indicate that p94 responds to the physical stress of myo-
cytes and that the mobility of p94 is regulated/facilitated by 
its protease activity.
How is p94’s protease activity involved in the regulation of 
mobility? It should be noted that p94’s protease activity is involved 
in both substrate degradation and autolysis. The activation of p94 
causes a limited processing of p94 itself (autoprocessing), resulting 
in a conformationally altered molecule that is still proteolytically 
Figure 4
Changes in MARP2 in WT and p94KI mice before and after exercise. (A and B) MARP2 protein detected in WT, WT-ex, p94KI, and p94KI-ex mice. 
The total extract of TA muscles was subjected to Western blot analysis using an anti-MARP2 Ab (representative blots are shown; see Supplemen-
tal Figure 7 for all the blots). In WT-ex and p94KI-ex mice, the muscles were isolated immediately after exercise. Hairlines indicate lanes that were 
run on the same gel but were noncontiguous. The full-length MARP2 bands (40 kDa, black arrowheads) were quantified (B) by normalizing them to 
the CBB-stained band for myosin heavy chain (Mhc) (CBB in A). *P < 0.05 versus WT; **P < 0.05 versus p94KI. (C–N) Induction of MARP2 in WT 
mice after exercise. Muscle cross-sections from WT (C–E and I–K), and p94KI (F–H and L–N) mice were stained with anti–laminin α2 (C, F, I, and 
L) and anti-MARP2 (D, G, J, and M) Abs. The WT-ex and p94KI-ex muscle samples were isolated immediately after exercise (I–N). Nuclei were 
visualized with DAPI (light blue in C, E, F, H, I, K, L, and N). Note that MARP2-positive myonuclei were detected in the exercised WT (arrowheads) 
sample. For observations of longitudinal sections and the specificity of the anti-MARP2 Ab, see Supplemental Figure 8. Scale bars: 50 μm.
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competent (25, 31–33). In fact, the proteolytic activity–dependent 
autoprocessing of p94 is detectable in exercised muscles as a faster 
migrating fragment of ca. 60 kDa (see Figure 2A). Therefore, the 
protease activity–dependent conformational changes in p94 might 
be important for p94’s proper dynamics within the sarcomere.
MARP2 is thought to be involved in stress-response path-
ways in skeletal muscles (17, 26, 28, 34, 35). The importance of 
MARP2’s induction for membrane repair is also supported by 
recent studies showing that MARP2-overexpressing muscle cells 
express elevated levels of genes for muscle repair systems, among 
others (36). Thus, the failure of MARP2 induction in p94KI-ex 
mice probably compromises the muscle’s adaptation to physi-
cal stress. We previously showed that p94 competes with MARP2 
for binding to the N2A region and that WT p94 is better able 
to abrogate the MARP2-N2A interaction than p94:C129S (17). 
Therefore, it is conceivable that the stretch-induced dynamic 
Figure 5
EBD uptake in the myofibers of exercised WT and p94KI mice. EBD-injected WT and p94KI mice were subjected to downhill running and then 
sacrificed immediately after exercise. Longitudinal cryostat sections of extensor digitorum longus (EDL) muscles were visualized with EBD auto-
fluorescence (A, D, G, and J), an anti-MARP2 Ab (B and E), or an anti-dysferlin Ab (H and K). Merged images are shown at right (C, F, I, and L). 
The uptake of EBD by myofibers was observed in both the WT-ex and p94KI-ex samples. (A–C) In the WT-ex mice, the EBD-positive myofibers 
had high MARP2 signals (white arrowheads), but not all the myofibers with high MARP2 signals were EBD positive (open arrowheads). (D–F) In 
the p94KI-ex mice, the myofibers with EBD uptake showed lower MARP2 signals (asterisks) than those from WT mice and were degenerating 
(see below). (G–I) In WT-ex mice, normal dysferlin staining (sarcolemma and striation) was observed in the EBD-positive myofibers, indicating 
that they were not degenerating (29, 30). (J–L) In the p94KI-ex mice, the EBD-positive myofibers showed abnormal dysferlin localization, indicat-
ing that the sarcolemma was disrupted and the fibers were degenerating (asterisks). Scale bars: 100 μm (A–F); 20 μm (G–L).
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Table 1
Protein expression profiles of WT and p94KI skeletal muscle before and after eccentric exercise
GI no. Protein name Gene % Cov WT-ex /WT P value p94KI-ex /p94KI P value p94KI /WT P value
[WT↑ and p94KI↑]A
 19387852 DNA mismatch repair protein; MutL homolog Mlh1	 1.3 1.21 1.6 × 10–01 1.95 1.1 × 10–02 1.00 9.4 × 10–01
 29294760 Ribosomal protein S6 kinase α-1 Rps6ka1	 2.6 1.81 4.5 × 10–02 1.70 4.0 × 10–01 2.06 9.0 × 10–02
 37359988 Brain-specific angiogenesis inhibitor 3 Bai3	 2.0 1.64 9.3 × 10–02 1.48 1.7 × 10–01 1.84 2.2 × 10–03
 313103 Myomesin, skelemin Myom1	 1.6 1.59 – 1.31 – 1.44 –
 74220201 Ubiquitin conjugating enzyme E2L3, UbcH7 Ube2l3	 10.7 1.70 – 1.24 – 1.71 –
 74186554 Nedd8 Nedd8	 25.0 1.39 – 1.20 – 1.42 –
 74178118 Transferrin Trf	 18.9 1.35 5.0 × 10–04 1.20 1.8 × 10–02 1.01 8.9 × 10–01
 28302235 5'-to-3' DNA helicase homolog Pif1	 2.3 1.40 – 1.16 – 1.42 –
 34785384 2-Oxoglutarate dehydrogenase E1 component Ogdh	 9.8 1.15 3.2 × 10–02 1.15 1.8 × 10–01 1.14 7.8 × 10–02
 29244166 SH3 and cysteine-rich domain 3 Stac3	 6.4 1.55 – 1.14 – 1.48 –
 58477305 Muscle-restricted coiled-coil protein Murc	 4.0 1.44 3.0 × 10–02 1.14 6.1 × 10–02 1.11 5.5 × 10–01
 6753912 Ferritin heavy chain 1 Fth1	 8.2 1.61 – 1.13 – 1.29 –
 149257950 28S Ribosomal protein S36, S36mt Mrps36	 17.6 1.33 – 1.12 – 1.86 –
 74223108 Dihydrolipoamide dehydrogenase Dld	 13.6 1.36 3.1 × 10–02 1.10 1.4 × 10–01 1.29 1.8 × 10–02
[WT↑ and p94KI → or ↓]B
 21304450 Immunoglobulin gamma 1 heavy chain Ighg1	 5.0 2.66 6.8 × 10–02 0.97 8.6 × 10–01 1.31 2.2 × 10–01
 40644653 Kinesin family member 15 Kif15	 1.3 2.53 4.5 × 10–03 1.07 3.1 × 10–01 2.87 1.2 × 10–02
 187957266 Filamin Cγ Flnc	 0.9 1.79 3.2 × 10–01 0.66 3.2 × 10–01 1.80 4.0 × 10–01
 74227220 Hydroxyacyl glutathione hydrolase Hagh	 8.1 1.75 – 0.84 – 1.90 –
 74151744 Proteasome subunit, α4 Psma4	 4.2 1.72 1.8 × 10–01 1.05 7.9 × 10–01 1.45 2.9 × 10–01
 76779273 Chaperonin, HSP60, HSPD1 Hspd1	 2.7 1.65 – 1.06 – 1.64 –
 51890211 Leu-rich repeat containing 8 family E Lrrc8e	 1.3 1.60 6.4 × 10–02 0.81 6.2 × 10–01 1.55 2.3 × 10–01
 13507646 Heat shock protein 8, sHSPB8	 Hspb8	 12.2 1.59 – 0.79 – 3.60 –
 31542970 Cardiovascular heat shock protein	 Hspb7	 7.7 1.59 1.9 × 10–02 0.76 3.8 × 10–02 1.30 8.0 × 10–02
 6754724 Proteasome 26S subunit, non-ATPase, 7 Psmd7	 6.2 1.55 2.1 × 10–01 0.85 7.6 × 10–01 1.24 7.9 × 10–01
 7305143 Hexokinase 2 Hk2	 0.9 1.47 7.2 × 10–02 1.09 5.2 × 10–01 1.70 1.7 × 10–01
 74147026 Heat shock protein 90 kDa α, class B1 Hsp90ab1	 15.2 1.44 1.7 × 10–03 0.92 2.1 × 10–01 1.42 7.3 × 10–03
 548879 Ras suppressor protein 1 (Rsu-1) (RSP-1) Rsu1	 6.1 1.42 – 0.67 – 1.71 –
 82795783 Eukaryotic translation elongation factor 1γ, eEF-1γ Eef1g	 2.6 1.40 5.3 × 10–01 0.87 8.8 × 10–02 1.39 6.3 × 10–01
 148685426 Tu translation elongation factor, mitochondrial Tufm	 8.3 1.38 5.1 × 10–02 1.07 7.1 × 10–01 1.39 8.1 × 10–02
 6753530 Crystallin, αB	 Cryab	 48.6 1.33 1.1 × 10–03 0.76 6.0 × 10–04 1.29 6.8 × 10–03
 158937312 Heat shock protein 1, sHSPB1	 Hspb1	 48.8 1.30 1.2 × 10–02 0.72 3.8 × 10–03 1.37 2.6 × 10–02
 74224118 Radixin isoform a Rdx	 6.8 1.28 1.7 × 10–01 1.07 4.6 × 10–01 1.28 2.1 × 10–01
 74177941 Hsc70 interacting protein St13	 3.2 1.28 4.9 × 10–02 0.86 1.4 × 10–01 1.36 6.9 × 10–02
 59958370 Heat shock protein, α-crystallin-related, B6	 Hspb6	 14.2 1.23 1.5 × 10–02 0.91 8.1 × 10–02 1.27 4.2 × 10–02
 26380702 Chaperone, ABC1 activity of bc1 complex like Cabc1	 1.4 1.23 1.3 × 10–01 0.85 1.6 × 10–02 1.16 3.6 × 10–01
 74147276 Proteasome 26S subunit, ATPase 2 Psmc2	 3.0 1.21 5.8 × 10–01 0.98 8.1 × 10–01 0.95 8.2 × 10–01
 61098127 Heat shock protein 2, sHSPB2	 Hspb2	 10.4 1.19 8.1 × 10–01 1.08 3.7 × 10–02 1.05 6.3 × 10–01
 18044689 Ser (or Cys) peptidase inhibitor, clade A-3K Serpina3k	 3.6 1.19 1.4 × 10–01 0.91 4.0 × 10–02 1.52 9.4 × 10–02
 9910130 Ankyrin repeat domain 2, ANKRD2, MARP2 Ankrd2	 4.6 1.18 – 0.73 – 1.15 –
 148685498 Aldolase A, fructose-bisphosphate Aldoa	 81.3 1.11 3.3 × 10–02 0.90 1.4 × 10–02 1.24 1.4 × 10–03
 122889668 Alanyl-tRNA synthetase domain containing 1 Aarsd1	 1.8 1.10 2.0 × 10–02 1.08 6.5 × 10–01 1.10 5.1 × 10–01
[p94KI↑ or ↓ and WT→]A
 54607128 Programmed cell death protein 11, ALG-4 Pdcd11	 0.8 1.00 9.7 × 10–01 1.45 3.4 × 10–02 0.86 7.0 × 10–02
 31982861 Carbonic anhydrase 3 Car3	 59.2 1.01 7.4 × 10–01 1.26 1.7 × 10–16 0.90 1.1 × 10–02
 2340058 Troponin T Tnnt3	 29.2 1.09 4.7 × 10–02 0.90 3.0 × 10–03 1.20 2.8 × 10–03
 156257677 β-Globin Hbb-b1	 44.9 0.97 2.9 × 10–01 0.89 1.2 × 10–07 1.12 1.9 × 10–02
 74204028 Dihydrolipoamide S-succinyltransferase Dlst	 7.9 1.00 9.9 × 10–01 0.87 1.7 × 10–03 1.01 9.9 × 10–01
 82617575 Glutamyl-prolyl-tRNA synthetase Eprs	 1.8 0.98 8.4 × 10–01 0.86 3.0 × 10–02 0.94 5.0 × 10–01
 6678391 Troponin I, skeletal, fast 2 Tnni2	 55.5 0.98 7.8 × 10–01 0.83 3.0 × 10–04 1.22 1.4 × 10–01
 74147564 Nicotinamide phosphoribosyltransferase Nampt	 1.6 1.05 7.8 × 10–01 0.82 3.5 × 10–02 1.21 5.1 × 10–01
[WT↓ and p94KI↑ or →]B
 50510361 Peroxiredoxin 6 Prdx6	 8.4 0.59 – 1.22 – 0.40 –
 6753290 Calsequestrin 1 Casq1	 14.0 0.90 1.4 × 10–02 1.28 1.2 × 10–07 0.83 3.4 × 10–04
 6671762 Creatine kinase, muscle Ckm	 90.0 0.88 1.4 × 10–15 1.07 8.7 × 10–18 0.92 1.5 × 10–04
 74144566 DnaJ (Hsp40) homolog, subfamily B14 Dnajb14	 5.1 0.77 9.4 × 10–08 1.01 6.2 × 10–02 0.74 2.8 × 10–07
 31982522 Acyl-coenzyme A dehydrogenase, short chain Acads	 8.3 0.83 1.7 × 10–01 1.01 3.9 × 10–01 0.80 1.6 × 10–02
 84794552 Phosphatidylethanolamine-binding protein 1 Pebp1	 46.5 0.82 1.2 × 10–02 1.00 9.6 × 10–01 0.70 6.7 × 10–03
 31980767 Parvalbumin Pvalb	 88.2 0.79 3.5 × 10–07 0.99 7.0 × 10–01 0.69 3.6 × 10–12
 7949078 Myosin regulatory light chain 2, fast skeletal muscle Mylpf	 13.6 0.82 7.3 × 10–02 0.97 7.0 × 10–01 0.82 2.5 × 10–02
 74225421 ATP synthase subunit β, mitochondrial Atp5b	 19.7 0.86 2.0 × 10–02 0.97 5.7 × 10–01 0.91 2.7 × 10–01
 148709839 Insulin degrading enzyme Ide	 0.7 0.82 1.4 × 10–02 0.93 1.1 × 10–01 0.92 1.7 × 10–01
 13385680 2,4-Dienoyl CoA reductase 1, mitochondrial Decr1	 4.5 0.66 6.8 × 10–02 0.92 1.1 × 10–02 0.59 9.6 × 10–02
 21359820 Myoglobin Mb	 85.7 0.78 9.3 × 10–19 0.92 4.7 × 10–03 0.64 2.6 × 10–27
[WT↓ and p94KI↓]A
 29789016 Fast skeletal myosin alkali light chain 1f Myl1	 49.5 0.80 9.0 × 10–05 0.82 4.0 × 10–05 0.89 7.8 × 10–03
 171906557 Peptidyl arginine deiminase, type II Padi2	 5.6 0.88 4.7 × 10–02 0.80 6.2 × 10–03 0.93 2.2 × 10–01
 6678371 Fast skeletal muscle troponin C Tnnc2	 7.5 0.64 7.7 × 10–02 0.74 4.1 × 10–01 0.84 2.1 × 10–01
Relative protein amounts of WT, WT-ex, p94KI, and p94KI-ex mice were analyzed by iTRAQ-labeling, 2D-LC-MALDI-TOF/TOF, and ProteinPilot. Proteins that have %Cov (ratio 
of a sum of unique aa residues in the detected peptides to the number of aa residues of the full-length protein) of nonzero value and show WT-ex/WT > 1.1 or < 0.91, p94KI-ex/
p94KI > 1.1 or < 0.91, or P < 0.05 are listed here with classification of 5 categories (defined after exercise) as indicated. Definitions of categories are as follows: [WT↑ and p94KI↑], 
WT-ex/WT and p94KI-ex/p94KI > 1.1; [WT↑ and p94KI → or ↓], WT-ex/WT > 1.1 and p94KI-ex/p94KI < 1.1; [p94KI↑ or ↓ and WT→], 1.1 > WT-ex/WT > 0.91 and [p94KI-ex/p94KI 
> 1.1 or < 0.91]; [WT↓ and p94KI↑ or →], WT/WT-ex > 1.1 and p94KI/p94KI-ex < 1.1; [WT↓ and p94KI↓] WT/WT-ex and p94KI/p94KI-ex > 1.1. ↑, upregulated; ↓, downregulated; 
→, unchanged. Bold text indicates hsp; underlined text indicates small hsp. ASorted by p94KI-ex/p94KI values. BSorted by WT-ex/WT values. Data shown here are from the same 
data set shown in Supplemental Figure 10; refer to its legend for details.
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redistribution of p94 from the M-line to the N2A region modu-
lates the dissociation of MARP2 from connectin/titin and the 
subsequent translocation of MARP2 to the nucleus to trans-
mit signals of mechanical perturbation and that this process is 
compromised in p94KI mice (Figure 6). In other words, the loss 
of p94 protease activity may disrupt a MARP2-mediated stress-
response pathway, resulting in muscle degeneration. This notion 
is also supported by the observations that exercise induces p94 
proteolytic activity and the upregulated transcription of MARP2 
in human skeletal muscles (20, 27) and that p94 is mislocalized 
in LGMD2A patients (37).
We noted a striking similarity in the proteomic profiles of mus-
cle cytosol in p94KI and WT-ex mice, including upregulation of 
hsp, likely indicating that the skeletal muscle of p94KI mice is 
in a permanent stress state like that caused by eccentric exercise 
in WT mice. Conversely, the very mild symptoms of p94KI mice 
can be ascribed to the upregulation of hsp. Upon exercise, since 
p94 translocates to the cytosol, the relative amounts of p94 in 
the M-line decrease. Indeed, our iTRAQ experiments detected 
an approximately 1.2- to 1.6-fold increase in myomesin 1 and 2, 
the major proteins in the M-line, in WT-ex and p94KI mice, sug-
gesting that p94 is one of the proteases responsible for myomesin 
degradation. In the cytosol, muscle type CK (CK-M) is a candi-
date target for p94 proteolysis since CK-M decreases with exer-
cise in WT mice, but does not significantly change in p94KI mice. 
On the other hand, in WT mice, exercise upregulated proteins 
involved in protein turnover, e.g., ubiquitin-related molecules 
(UbcH7, Nedd8), proteasome subunits (PSMA4, C2, D7), and 
proteins related to translation (S36mt, EF-Tu, eEF-1γ, RSK-1). 
This can be explained by the change in p94 localization and/or 
by hypothesizing that its degrading protease or proteases are 
downregulated by p94. Some of these proteins (proteasome 
subunits, EF-Tu, and eEF-1γ) are not upregulated or are even 
downregulated in p94KI-ex mice, suggesting that they are under 
the control of p94 protease activity.
Although CK levels are elevated in LGMD2A patients with a 
CAPN3-null mutation, in p94KO mice, and in patients with other 
MDs (3, 11, 13), our p94KI mice did not exhibit an elevated CK 
value when unexercised. Similarly, some LGMD2A patients that 
express an apparently normal-sized p94 protein with missense 
mutations, such as P359L, show almost normal CK values (38). 
Considering that P359L, which is adjacent to one of the active-site 
residues (N358), is likely to impair the p94 protease activity, these 
findings suggest that a novel function of p94, not its protease 
activity, is involved in the maintenance of the sarcolemma. Further 
studies will be required to elucidate this function, which may be 
facilitated by comparing the p94KI mice with the p94KO mice.
Previous studies have demonstrated that the protein dynamics 
of the highly organized sarcomere are important for the sarco-
mere’s structural integrity (39). Given that p94KI-ex showed an 
exacerbated MD phenotype, we suggest that the decreased ability 
of inactive p94 to swiftly change its distribution in response to 
physical stress results in a delayed or inadequate adaptive response 
of the myocytes to physical stress, which contributes to MD patho-
genesis. Thus, it is plausible that p94 functions as a sensor that 
detects physical stress through stretch-dependent autoprocessing. 
Since skeletal muscles are exceptionally adaptable to a variety of 
stimuli (exercise, denervation, starvation, hypoxia, invasive sur-
gery, trauma, etc.), they must require cellular machinery for the 
qualitative and quantitative sensing of these stimuli. In this con-
text, p94 is an excellent candidate as a sensor for the intensity of 
physical stress. Our results demonstrating the importance of spa-
Figure 6
A model for the p94-mediated signal response to physical 
stress. In WT mice, when skeletal muscles undergo physi-
cal stress such as exercise, p94WT accumulates at the N2A 
region and MARP2 translocates from the N2A region to the 
myonuclei to promote the adaptive response to stress. 
In contrast, in the p94KI mice, in response to physical 
stress, the p94:C129S protein accumulates slowly at the 
N2A region, and the MARP2 induction is lower than in WT 
mice. Consequently, MARP2 signaling does not function 
properly in the p94KI mice. Thus, the p94 protease activity 
is required for the adaptive response to physical stress in 
skeletal muscles. Black and gray arrows indicate the proper 
and compromised mobility in response to physical stress in 
WT and p94KI mice, respectively.
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tiotemporally regulated p94 behavior in the protective response of 
skeletal muscles provide what we believe are novel and important 
insights into the complex pathogenesis of LGMD2A as well as 
ideas for the development of future therapeutic strategies. In addi-
tion, our observations may be important for understanding how 
physical stress in skeletal muscles is connected to adaptive cellular 
responses, although the precise molecular mechanisms should be 
further investigated.
Methods
Experimental animals. All procedures using experimental animals were 
approved by the Experimental Animal Care and Use Committee of Rinsho-
ken, and the animals were treated according to the committee’s guidelines. 
C57BL/6 mice were purchased from Nihon CLEA Inc. Cre-recombinase–
expressing Tg-mice were provided by the Jackson Laboratory.
Construction of the targeting vector and generation of p94KI. The missense 
C129S mutation and a neomycin-resistance gene (neoR) flanked by loxP 
sequences were introduced into exon 3 and intron 3, respectively, of the 
Capn3 gene in mouse ES cells by electrotransfection of the targeting vec-
tor (Supplemental Figure 1A). The recombinant ES cells were used for 
blastocyst injection to produce germline-transmitting chimeric mice. F1 
heterozygotes with the proper recombination were crossed with Tg mice 
expressing Cre recombinase in their germline cells. The resultant mice were 
confirmed by Southern blot analysis to have the C129S mutation without 
neoR and were backcrossed with C57BL/6J mice for more than 8 genera-
tions (see Supplemental Figure 1 for details).
Mouse running protocol and serum CK measurement. An exercise protocol was 
designed as previously reported (40) with slight modification. Briefly, WT 
and p94KI mice (15 to 18 weeks old) were made to run on motor-driven 
treadmills (MK-680S; Muromachi Inc.). The running program was as fol-
lows: (16° decline, 18 m/min × 20 min) × 3 sets with 3-minute intervals 
between each set. Muscle and blood samples were taken immediately after 
the exercise unless otherwise stated. For the EBD assay, 2% EBD in PBS 
was injected intravenously immediately after exercise (10 μl/g body weight) 
(41), and the mice were sacrificed the next day. Since this protocol showed 
almost no EBD-stained myofibers in WT mice, in another set of experi-
ments, EBD was preinjected before exercise, and the mice were sacrificed 
immediately afterwards. The dissected muscles were immediately frozen in 
liquid nitrogen–cooled isopentane.
For the serum CK measurement, blood was taken from the heart 
under anesthesia. To prevent nonspecific increases in the CK value, a 
single blood draw per sample was used for quantification. Serum CK 
was measured by SRL Inc.
Histology and Western blot analysis. H&E staining and immunochemical 
labeling were performed as previously reported (42). Fluorescence was 
observed on a laser-scanning confocal microscope (Zeiss LSM510). The 
images were manipulated with LSM imaging software. The number of 
myofibers and CNM were counted in H&E-stained sections. The CSArs 
of myofibers were measured with AlphaEaseFC Software ver. 3.1.2 (Alpha 
InnoTech Corp.). Western blot analysis was performed as previously 
described (19). Skeletal muscles were lysed with TED buffer (10 mM Tris/
Cl [pH 7.5], 1 mM EDTA, 1 mM DTT). The Sup and Ppt fractions were 
prepared by centrifugation at 23,000 g for 20 minutes. The intensity of the 
bands was normalized to that of the CBB-stained actin or Mhc band. The 
primary Abs used in this study are listed in Supplemental Table 2.
Quantification of the p94 signal in sarcomeres. After staining with the anti-
pNS Ab, which detects p94 (43), the average signal intensities of p94 in 
the M and N2A zones were quantified with Photoshop CS2 (Adobe). The 
p94 signal ratio in a single sarcomere was calculated as the ratio of the 
p94 signal density in M to the p94 signal density in N2A. Each value was 
plotted on a scatter graph in relation to the sarcomeric length, which was 
measured as the distance between the centers of adjacent s-α-actinin–posi-
tive Z-lines with LSM imaging software. The total number of sarcomeres 
counted was 195 for WT and 188 for p94KI.
EM study. EDL muscles were fixed with 2% glutaraldehyde, postfixed with 
1% OsO4, and embedded in Epon. Ultrathin sections were stained with 
uranyl acetate and examined using a JEM 1200EX transmission electron 
microscope (JEOL).
Muscle culture, transfection, and FRAP. The preparation of mouse skeletal 
muscle primary culture cells and transfection were carried out as previously 
described (19). The cDNAs for full-length human p94 and its protease-inac-
tive form p94:C129S were cloned into the pEGFP vector (Clontech). Five 
days after switching to differentiation medium, myocytes transfected with 
an expression vector encoding a WT p94-EGFP fusion protein, p94:C129S-
EGFP fusion protein, or EGFP (pEGFP mock vector) were subjected to FRAP 
analysis with an LSM510 confocal microscope. The regions of interest were 
bleached for 30 seconds using LSM software. For control experiments using 
pEGFP, 30 seconds of photobleaching reduced the EGFP signal by only about 
50%, because of the rapid mobility of the EGFP molecules (see Supplemental 
Figure 5). The FRAP process was recorded using LSM software. For the FRAP 
experiments using p94-fused EGFP, the relative EGFP intensity was calcu-
lated as the ratio of EGFP intensity at each time point to the intensity before 
bleaching and the t1/2 for recovery was calculated as reported previously (22). 
Ten fibers each were quantified for WT p94 and p94:C129S.
To calculate the mobile fraction (M1, M2, . . . ) and recovery t1/2, first, the 
value of the initial photobleached image (t = 0) was subtracted from each 
subsequent image, and the results were normalized by setting the prebleach 
intensity to 1 and the intensity of the initial photobleached image (t = 0) 
to 0. A curve-fitting method was used to extract M1 and t1/2 from the FRAP 
curve, as previously reported (22). MS-Excel was used to fit the data to the 
following exponential equation: r = M1(1 – exp[–k1t]), where R is the relative 
recovery of the fluorescence intensity of the bleached area at time t, and M1 
is the mobile fraction of the exponential process with rate constant k1. t1/2 
was calculated as t1/2 = 0.69315/k1. Note that this equation fit the data well, 
and a dual exponential fit did not improve the fit.
iTRAQ labeling and data analysis. Buffer (0.5 M triethylammonium bicar-
bonate, 0.1% SDS) soluble fractions of TA muscles were prepared from 
unexercised WT and p94KI mice and WT-ex and p94KI-ex mice immedi-
ately after exercise. Each sample (45 μg of protein) was a mixture of equal 
amounts of protein from 3 individual mice and labeled with iTRAQ–114 
(WT), –115 (p94KI), –116 (WT-ex), or –117 (p94KI-ex) reagents according 
to the manufacturer’s instructions (ABI). The samples were subjected to 
fractionation (1,440 spots) using a DiNa LC system with HiQ-Sil-SCX, HiQ-
Sil-C18-3, and a MALDI-plate spotter (KYA Tech) as described previously 
(44). Spotted fractions were analyzed by MALDI-TOF mass spectrometry 
(ABI 4800), and proteins were identified using ProteinPilot 2.0 (ABI) and 
Swiss-Prot Database. ProteinPilot 2.0 software detected 4,965 distinct pep-
tides for 660 proteins from 14,660 MS/MS spectra (confidence > 0.7). See 
Supplemental Figure 10 for details.
DNA microarray analysis. Poly(A)+ RNA was isolated from TA muscles of 
WT and p94KI (2 for each). DNA microarray analysis was performed using 
an Affymetrix DNA chip U74A according to the manufacturer’s instruc-
tions and as previously described (18).
Statistics. Statistical analyses were performed by the 2-tailed Student’s 
t test to determine statistical significance. P (exact significance) < 0.05 
was considered statistically significant. As for statistical significance of 
k (= 0.69315/t1/2) described in Figure 3, C and P, several independent analy-
ses were done (see Supplemental Figure 6 for details). Error bars denote 
SEM. Calculations were performed using Origin 8 Pro (OriginLab Corp.), 
MS Excel (Microsoft Corp.), and/or “R” program package (45).
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